| Title | A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1) |
|---|---|
| Disease/Condition | Blood and Bone Marrow Cancer |
| Eligibility Criteria | Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
| Principal Investigator | Ira Braunschweig, MD |
| Contact Name | Karen Fehn |
| Phone | (718) 405-8446 |
| Contact Email | CPDMUtrialinfo@montefiore.org |
| IRB/Protocol Number | IRB# 15-11-37-01 |
| Status | Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |